Real-world Research : Assessment of Effect of Combination of Drugs in the Treatment of Heart Failure
NCT06158711 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 702
Last updated 2023-12-06
Summary
The goal of this observational study is to assess the effect of the different combination of drugs in the treatment of heart failure.
The main questions it aims to answer are:
* \[question 1\] The changes of BNP and LVEF in patients of each groups with different drugs co-administration.
* \[question 2\] The days of hospitalization, degree of lower limb edema (mild, moderate, severe) and 6-minute walking test in each groups.
Participants will be asked to do nothing. All the records of the patients will be download from the Big Data Cloud Platform of Health Care in the First Affiliated Hospital of Shandong First Medical University.
There is not a comparison group.
Conditions
Sponsors & Collaborators
-
Qianfoshan Hospital
lead OTHER
Principal Investigators
-
Guang Yang, PhD · Qianfoshan Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-30
- Primary Completion
- 2024-01-31
- Completion
- 2024-07-31
More Related Trials
-
A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure
NCT07218627 ·Status: RECRUITING ·Phase: PHASE1
-
Double Blind Randomized Placebo Controlled Trial of Natrecor in Acute Decompensated Heart Failure With Normal EF
NCT00505791 ·Status: WITHDRAWN ·Phase: PHASE4
-
The Comparative Effectiveness Between ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF
NCT05329727 ·Status: RECRUITING
-
Determination of Drug Levels for Pharmacotherapy of Heart Failure
NCT06035978 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effects of Sacubitril/Valsartan on Exercise Capacity, Natriuretic Peptides and Ventricular Remodeling in Heart Failure
NCT04434170 ·Status: COMPLETED
-
Tapering Heart Failure Medication in Patients With Heart Failure With Recovered Ejection Fraction; Open Label Prospective Random Trial
NCT06724653 ·Status: RECRUITING ·Phase: NA
-
Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients?
NCT01437371 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure
NCT00742508 ·Status: COMPLETED ·Phase: PHASE1
-
Role of Sacubitril/Valsartan in the Improvement of Heart Failure With Reduced Ejection Fraction
NCT04397302 ·Status: COMPLETED
-
Dapa Acute Heart Failure Study
NCT05759000 ·Status: RECRUITING
-
Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure
NCT00252187 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparison of BNP and NT-proBNP in the Management of Patients With Chronic and Acute Heart Failure
NCT04107220 ·Status: UNKNOWN ·Phase: NA
-
Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid Retention
NCT07318103 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular Remodeling Among Diabetic and Non Diabetic Patients With Chronic Heart Failure
NCT06137430 ·Status: NOT_YET_RECRUITING
-
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
NCT03357731 ·Status: COMPLETED ·Phase: PHASE2
-
The Bio-Clinical Effects of the (Sacubitril-Valsartan) Combination on Patients With Chronic Heart Failure
NCT04688294 ·Status: COMPLETED ·Phase: PHASE4
-
SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction
NCT05583773 ·Status: RECRUITING ·Phase: PHASE4
-
Early rhBNP on Myocardial Work in Patients With STEMI
NCT04157868 ·Status: UNKNOWN ·Phase: PHASE4
-
The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation
NCT04217135 ·Status: UNKNOWN ·Phase: PHASE4
-
Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Remodeling
NCT05606718 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patients
NCT02344641 ·Status: UNKNOWN ·Phase: NA
-
A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure
NCT01120210 ·Status: COMPLETED ·Phase: PHASE2
-
Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac Hypertrophy
NCT05953831 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MI
NCT03552575 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics of Bisoprolol and SGLT2i in Acutely Decompensated Heart Failure
NCT06453577 ·Status: ACTIVE_NOT_RECRUITING